Point of Care/Rapid Diagnostics Market (by Product: (Glucose, Infectious Disease (Hepatitis C, Influenza), Coagulation), Platform (Microfluidics, Immunoassay), Mode of Purchase (Prescription, OTC), Enduser (Hospital, e-comm, Home Care) - Global Industry Analysis, Share ,Growth ,Regional Outlook And Forecasts, 2021-2027

The global Point of CareRapid Diagnostics market gathered revenue around USD 28.9 Billion in 2020 and market is set to grow USD 54.6 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 10.9% during the prediction period 2021 to 2027. 

Point of Care/Rapid Diagnostics Market Size 2020 to 2027

Growth Factors:

The marke Factors such as the technological advancements in point of care devices in the market are propelling the growth of the market. Additionally, rising cases of investments from both private and public sectors boosting the research activities are likely to have effect in the growth of point of care diagnostics market. However, lack of proper alignment of POCs with central lab methods, and lower adoption, due to lack of knowledge regarding the use of PoC products for indicative diseases in many low resource economies are likely to hamper the growth of this market.

The recent COVID-19 global pandemic has also impacted the point of care diagnostics market. Demand from the main end-users has increased as key regions and countries demanded for rapid testing kits in order to detect the COVID infection at the earliest. The rapidly growing number of COVID-19 cases and the growing pressure on governments to improve patient management has boosted the demand for rapid testing kits that can be effectively used in point-of-care settings..

This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Point of CareRapid Diagnostics market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Point of CareRapid Diagnostics market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.

Report Coverage

Report Scope Details
Market Size USD 54.6 Billion by 2027
Growth Rate CAGR of 10.9% From 2021 to 2027
Base Year 2020
Forecast Period 2021 to 2027
Historic Data 2017 to 2020
Report coverage Growth Factors, Revenue Status, Competitive Landscape,  and Future Trends
Segments Covered Product, Platform, Mode of Purchase, End Users and Region
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Companies Mentioned Roche Diagnostics , Abbott Laboratories , Siemens Healthineers , Becton, Dickinson and Company , Johnson & Johnson , Danaher Corporation , Chembio Diagnostics , Quidel Corporation, EKF Diagnostics , Trinity Biotech , AccuBioTech , Nova Biomedical , PTS Diagnostics , Instrumentation Laboratory Company , and Sekisui Diagnostics .

COVID-19 Impact Assessment on Market Landscape

The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.

Point of CareRapid Diagnostics market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.

North America is the largest regional market for Point of care diagnostics

North America (comprising the US and Canada) dominates point of care diagnostics market. North America is a gaining traction with the increasing incidence and prevalence of lifestyle diseases. Moreoer resence of major key platers in the region, facourable government scenarios, higher awarness of self tetsing and home care products and significant adoption of novel technologies are likely to paly a major role in fueling the growth of the point of care diagnostics market in the North America.

Competitive Rivalry

Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.

Significant Market Participants Operational in the Point of CareRapid Diagnostics Market are: Roche Diagnostics , Abbott Laboratories , Siemens Healthineers , Becton, Dickinson and Company , Johnson & Johnson , Danaher Corporation , Chembio Diagnostics , Quidel Corporation, EKF Diagnostics , Trinity Biotech , AccuBioTech , Nova Biomedical , PTS Diagnostics , Instrumentation Laboratory Company , and Sekisui Diagnostics .

Unravelling the Critical Segments

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:

By Product

  • Glucose Monitoring Products
  • Cardiometabolic Monitoring Products
  • Infectious Disease Testing Products
  • Coagulation Monitoring Products
  • Pregnancy & Fertility Testing Products
  • Fecal Occult Testing Products
  • Hematology Testing Products
  • Tumor/Cancer Marker Testing Products
  • Urinalysis Testing Products
  • Drugs-of-abuse Testing Products
  • Cholesterol Testing Products
  • Other POC Products

By Platform

  • Lateral Flow Assays
  • Immunoassays
  • Microfluidics 1
  • Molecular Diagnostics
  • Dipsticks

By Mode of Purchase

  • OTC Testing Products
  • Prescription-based Testing Products

By End Users

  • Outpatient & Ambulatory Care Facilities
  • Hospitals & Critical Care Centers
  • Home Care Settings 5
  • Other End Users

By Geography

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Rest of Latin America

Middle East & Africa (MEA)

  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa

Chapter 1.    Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.    Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.    Executive Summary

3.1.  Market Snapshot

Chapter 4.    Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.     Raw Material Procurement Analysis

4.3.2.     Sales and Distribution Channel Analysis

4.3.3.     Downstream Buyer Analysis

Chapter 5.    Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.     Market Drivers

5.1.2.     Market Restraints

5.1.3.     Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.     Bargaining power of suppliers

5.2.2.     Bargaining power of buyers

5.2.3.     Threat of substitute

5.2.4.     Threat of new entrants

5.2.5.     Degree of competition

Chapter 6.    Competitive Landscape

6.1.1.     Company Market Share/Positioning Analysis

6.1.2.     Key Strategies Adopted by Players

6.1.3.     Vendor Landscape

6.1.3.1.          List of Suppliers

6.1.3.2.          List of Buyers

Chapter 7.    Global Point Of Care/Rapid Diagnostics Market, By Product

7.1.  Point Of Care/Rapid Diagnostics  Market, By Product, 2021-2027

7.1.1.     Glucose Monitoring Products

7.1.1.1.          Market Revenue and Forecast (2016-2027)

7.1.2.     Cardiometabolic Monitoring Products

7.1.2.1.          Market Revenue and Forecast (2016-2027)

7.1.3.     Infectious Disease Testing Products

7.1.3.1.          Market Revenue and Forecast (2016-2027)

7.1.4.     Coagulation Monitoring Products

7.1.4.1.          Market Revenue and Forecast (2016-2027)

7.1.5.     Pregnancy & Fertility Testing Products

7.1.5.1.          Market Revenue and Forecast (2016-2027)

7.1.6.     Fecal Occult Testing Products

7.1.6.1.          Market Revenue and Forecast (2016-2027)

7.1.7.     Hematology Testing Products

7.1.7.1.          Market Revenue and Forecast (2016-2027)

7.1.8.     Tumor/Cancer Marker Testing Products

7.1.8.1.          Market Revenue and Forecast (2016-2027)

1.1.1.     Tumor/Cancer Marker Testing Products

1.1.1.1.          Market Revenue and Forecast (2016-2027)

1.1.2.     Urinalysis Testing Products

1.1.2.1.          Market Revenue and Forecast (2016-2027)

1.1.3.     Drugs-of-abuse Testing Products

1.1.3.1.          Market Revenue and Forecast (2016-2027)

1.1.4.     Cholesterol Testing Products

1.1.4.1.          Market Revenue and Forecast (2016-2027)

1.1.5.     Other POC Products

1.1.5.1.          Market Revenue and Forecast (2016-2027)

Chapter 2.    Global Point Of Care/Rapid Diagnostics Market, By Platform

2.1.  Point Of Care/Rapid Diagnostics  Market, By Platform, 2021-2027

2.1.1.     Lateral Flow Assays

2.1.1.1.          Market Revenue and Forecast (2016-2027)

2.1.2.     Immunoassays

2.1.2.1.          Market Revenue and Forecast (2016-2027)

2.1.3.     Microfluidics 1

2.1.3.1.          Market Revenue and Forecast (2016-2027)

2.1.4.     Molecular Diagnostics

2.1.4.1.          Market Revenue and Forecast (2016-2027)

2.1.5.     Dipsticks

2.1.5.1.          Market Revenue and Forecast (2016-2027)

Chapter 3.    Global Point Of Care/Rapid Diagnostics Market, By Mode of Purchase

3.1.  Point Of Care/Rapid Diagnostics  Market, By Mode of Purchase, 2021-2027

3.1.1.     OTC Testing Products

3.1.1.1.          Market Revenue and Forecast (2016-2027)

3.1.2.     Prescription-based Testing Products

3.1.2.1.          Market Revenue and Forecast (2016-2027)

Chapter 4.    Global Point Of Care/Rapid Diagnostics Market, By End Users

4.1.  Point Of Care/Rapid Diagnostics  Market, By End Users, 2021-2027

4.1.1.     Outpatient & Ambulatory Care Facilities

4.1.1.1.          Market Revenue and Forecast (2016-2027)

4.1.2.     Hospitals & Critical Care Centers

4.1.2.1.          Market Revenue and Forecast (2016-2027)

4.1.3.     Home Care Settings 5

4.1.3.1.          Market Revenue and Forecast (2016-2027)

4.1.4.     Other End Users

4.1.4.1.          Market Revenue and Forecast (2016-2027)

Chapter 5.    Global Point Of Care/Rapid Diagnostics  Market, Regional Estimates and Trend Forecast

5.1.  North America

5.1.1.     Market Revenue and Forecast, By Product (2016-2027)

5.1.2.     Market Revenue and Forecast, By Platform (2016-2027)

5.1.3.     Market Revenue and Forecast, By Mode of Purchase (2016-2027)

5.1.4.     Market Revenue and Forecast, By End Users (2016-2027)

5.1.5.     U.S.

5.1.5.1.          Market Revenue and Forecast, By Product (2016-2027)

5.1.5.2.          Market Revenue and Forecast, By Platform (2016-2027)

5.1.5.3.          Market Revenue and Forecast, By Mode of Purchase (2016-2027)

5.1.5.4.          Market Revenue and Forecast, By End Users (2016-2027)

5.1.6.     Rest of North America

5.1.6.1.          Market Revenue and Forecast, By Product (2016-2027)

5.1.6.2.          Market Revenue and Forecast, By Platform (2016-2027)

5.1.6.3.          Market Revenue and Forecast, By Mode of Purchase (2016-2027)

5.1.6.4.          Market Revenue and Forecast, By End Users (2016-2027)

5.2.  Europe

5.2.1.     Market Revenue and Forecast, By Product (2016-2027)

5.2.2.     Market Revenue and Forecast, By Platform (2016-2027)

5.2.3.     Market Revenue and Forecast, By Mode of Purchase (2016-2027)

5.2.4.     Market Revenue and Forecast, By End Users (2016-2027)

5.2.5.     UK

5.2.5.1.          Market Revenue and Forecast, By Product (2016-2027)

5.2.5.2.          Market Revenue and Forecast, By Platform (2016-2027)

5.2.5.3.          Market Revenue and Forecast, By Mode of Purchase (2016-2027)

5.2.5.4.          Market Revenue and Forecast, By End Users (2016-2027)

5.2.6.     Germany

5.2.6.1.          Market Revenue and Forecast, By Product(2016-2027)

5.2.6.2.          Market Revenue and Forecast, By Platform (2016-2027)

5.2.6.3.          Market Revenue and Forecast, By Mode of Purchase (2016-2027)

5.2.6.4.          Market Revenue and Forecast, By End Users (2016-2027)

5.2.7.     France

5.2.7.1.          Market Revenue and Forecast, By Product (2016-2027)

5.2.7.2.          Market Revenue and Forecast, By Platform (2016-2027)

5.2.7.3.          Market Revenue and Forecast, By Mode of Purchase (2016-2027)

5.2.7.4.          Market Revenue and Forecast, By End Users (2016-2027)

5.2.8.     Rest of Europe

5.2.8.1.          Market Revenue and Forecast, By Product (2016-2027)

5.2.8.2.          Market Revenue and Forecast, By Platform (2016-2027)

5.2.8.3.          Market Revenue and Forecast, By Mode of Purchase (2016-2027)

5.2.8.4.          Market Revenue and Forecast, By End Users (2016-2027)

5.3.  APAC

5.3.1.     Market Revenue and Forecast, By Product (2016-2027)

5.3.2.     Market Revenue and Forecast, By Platform (2016-2027)

5.3.3.     Market Revenue and Forecast, By Mode of Purchase (2016-2027)

5.3.4.     Market Revenue and Forecast, By End Users (2016-2027)

5.3.5.     India

5.3.5.1.          Market Revenue and Forecast, By Product (2016-2027)

5.3.5.2.          Market Revenue and Forecast, By Platform (2016-2027)

5.3.5.3.          Market Revenue and Forecast, By Mode of Purchase (2016-2027)

5.3.5.4.          Market Revenue and Forecast, By End Users (2016-2027)

5.3.6.     China

5.3.6.1.          Market Revenue and Forecast, By Product (2016-2027)

5.3.6.2.          Market Revenue and Forecast, By Platform (2016-2027)

5.3.6.3.          Market Revenue and Forecast, By Mode of Purchase (2016-2027)

5.3.6.4.          Market Revenue and Forecast, By End Users (2016-2027)

5.3.7.     Japan

5.3.7.1.          Market Revenue and Forecast, By Product (2016-2027)

5.3.7.2.          Market Revenue and Forecast, By Platform (2016-2027)

5.3.7.3.          Market Revenue and Forecast, By Mode of Purchase (2016-2027)

5.3.7.4.          Market Revenue and Forecast, By End Users (2016-2027)

5.3.8.     Rest of APAC

5.3.8.1.          Market Revenue and Forecast, By Product (2016-2027)

5.3.8.2.          Market Revenue and Forecast, By Platform (2016-2027)

5.3.8.3.          Market Revenue and Forecast, By Mode of Purchase (2016-2027)

5.3.8.4.          Market Revenue and Forecast, By End Users (2016-2027)

5.4.  MEA

5.4.1.     Market Revenue and Forecast, By Product (2016-2027)

5.4.2.     Market Revenue and Forecast, By Platform (2016-2027)

5.4.3.     Market Revenue and Forecast, By Mode of Purchase (2016-2027)

5.4.4.     Market Revenue and Forecast, By End Users (2016-2027)

5.4.5.     GCC

5.4.5.1.          Market Revenue and Forecast, By Product (2016-2027)

5.4.5.2.          Market Revenue and Forecast, By Platform (2016-2027)

5.4.5.3.          Market Revenue and Forecast, By Mode of Purchase (2016-2027)

5.4.5.4.          Market Revenue and Forecast, By End Users (2016-2027)

5.4.6.     North Africa

5.4.6.1.          Market Revenue and Forecast, By Product (2016-2027)

5.4.6.2.          Market Revenue and Forecast, By Platform (2016-2027)

5.4.6.3.          Market Revenue and Forecast, By Mode of Purchase (2016-2027)

5.4.6.4.          Market Revenue and Forecast, By End Users (2016-2027)

5.4.7.     South Africa

5.4.7.1.          Market Revenue and Forecast, By Product (2016-2027)

5.4.7.2.          Market Revenue and Forecast, By Platform (2016-2027)

5.4.7.3.          Market Revenue and Forecast, By Mode of Purchase (2016-2027)

5.4.7.4.          Market Revenue and Forecast, By End Users (2016-2027)

5.4.8.     Rest of MEA

5.4.8.1.          Market Revenue and Forecast, By Product (2016-2027)

5.4.8.2.          Market Revenue and Forecast, By Platform (2016-2027)

5.4.8.3.          Market Revenue and Forecast, By Mode of Purchase (2016-2027)

5.4.8.4.          Market Revenue and Forecast, By End Users (2016-2027)

5.5.  Latin America

5.5.1.     Market Revenue and Forecast, By Product (2016-2027)

5.5.2.     Market Revenue and Forecast, By Platform (2016-2027)

5.5.3.     Market Revenue and Forecast, By Mode of Purchase (2016-2027)

5.5.4.     Market Revenue and Forecast, By End Users (2016-2027)

5.5.5.     Brazil

5.5.5.1.          Market Revenue and Forecast, By Product (2016-2027)

5.5.5.2.          Market Revenue and Forecast, By Platform (2016-2027)

5.5.5.3.          Market Revenue and Forecast, By Mode of Purchase (2016-2027)

5.5.5.4.          Market Revenue and Forecast, By End Users (2016-2027)

5.5.6.     Rest of LATAM

5.5.6.1.          Market Revenue and Forecast, By Product (2016-2027)

5.5.6.2.          Market Revenue and Forecast, By Platform (2016-2027)

5.5.6.3.          Market Revenue and Forecast, By Mode of Purchase (2016-2027)

5.5.6.4.          Market Revenue and Forecast, By End Users (2016-2027)

Chapter 6.      Company Profiles

6.1.  Roche Diagnostics (Switzerland)

6.1.1.     Company Overview

6.1.2.     Product Offerings

6.1.3.     Financial Performance

6.1.4.     Recent Initiatives

6.2.  Abbott Laboratories (US)

6.2.1.     Company Overview

6.2.2.     Product Offerings

6.2.3.     Financial Performance

6.2.4.     Recent Initiatives

6.3.  Siemens Healthineers (Germany)

6.3.1.     Company Overview

6.3.2.     Product Offerings

6.3.3.     Financial Performance

6.3.4.     Recent Initiatives

6.4.  Becton, Dickinson and Company(US)

6.4.1.     Company Overview

6.4.2.     Product Offerings

6.4.3.     Financial Performance

6.4.4.     Recent Initiatives

6.5.  Johnson & Johnson (US)

6.5.1.     Company Overview

6.5.2.     Product Offerings

6.5.3.     Financial Performance

6.5.4.     Recent Initiatives

6.6.  Danaher Corporation (US)

6.6.1.     Company Overview

6.6.2.     Product Offerings

6.6.3.     Financial Performance

6.6.4.     Recent Initiatives

6.7.  Chembio Diagnostics (US)

6.7.1.     Company Overview

6.7.2.     Product Offerings

6.7.3.     Financial Performance

6.7.4.     Recent Initiatives

6.8.  Quidel Corporation(US)

6.8.1.     Company Overview

6.8.2.     Product Offerings

6.8.3.     Financial Performance

6.8.4.     Recent Initiatives

6.9.  EKF Diagnostics (UK)

6.9.1.     Company Overview

6.9.2.     Product Offerings

6.9.3.     Financial Performance

6.9.4.     Recent Initiatives

6.10.                 Trinity Biotech (Ireland)

6.10.1.  Company Overview

6.10.2.  Product Offerings

6.10.3.  Financial Performance

6.10.4.  Recent Initiatives

6.11.                 AccuBioTech (China)

6.11.1.  Company Overview

6.11.2.  Product Offerings

6.11.3.  Financial Performance

6.11.4.  Recent Initiatives

6.12.                 Nova Biomedical (US)

6.12.1.  Company Overview

6.12.2.  Product Offerings

6.12.3.  Financial Performance

6.12.4.  Recent Initiatives

6.13.                 PTS Diagnostics (US)

6.13.1.  Company Overview

6.13.2.  Product Offerings

6.13.3.  Financial Performance

6.13.4.  Recent Initiatives

6.14.                 Instrumentation Laboratory Company (US)

6.14.1.  Company Overview

6.14.2.  Product Offerings

6.14.3.  Financial Performance

6.14.4.  Recent Initiatives

6.15.                 Sekisui Diagnostics (US)

6.15.1.  Company Overview

6.15.2.  Product Offerings

6.15.3.  Financial Performance

6.15.4.  Recent Initiatives

Chapter 7.      Research Methodology

7.1.  Primary Research

7.2.  Secondary Research

7.3.  Assumptions

Chapter 8.      Appendix

8.1.  About Us

8.2.  Glossary of Terms

 

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask To Expert